An Act amending the act of May 17, 1921 (P.L.682, No.284), known as The Insurance Company Law of 1921, in quality health care accountability and protection, further providing for definitions and providing for utilization management for stage four, advanced metastatic cancer drugs; and making a repeal.

Summary

The bill defines "stage four, advanced metastatic cancer" and adds a rule that health insurers cannot force patients to try and fail other treatments before covering a drug that is FDA‑approved for that condition and backed by best clinical practice and peer‑reviewed research. It repeals the 2020 Fair Access to Cancer Treatment Law but leaves its existing contracts and regulations in place. The goal is to improve access to effective therapies for patients with advanced cancer.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share